Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Sells MassArrays to South Korean Cancer Center, Two Other Customers

NEW YORK (GenomeWeb News) — Sequenom sold three of its MassArray analyzers in South Korea in the fourth quarter of 2006, the company said today.
 
The sales were made through Bioneer, a Daejeon-based genomics research products and services company that signed an exclusive deal with Sequenom in September 2006 to market and distribute the MassArray in South Korea.  
 
Sequenom said Bioneer sold one of its analysis systems to National Cancer Center of the Republic of Korea, but did not disclose the two other customers.
 
Bioneer president and CEO Han-Oh Park said the fourth-quarter sales “represent increased demand we are seeing in South Korea for fine mapping genetic analysis solutions, and for life sciences research tools in general.”
The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.